Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Nov 1;176(11):e223261.
doi: 10.1001/jamapediatrics.2022.3261. Epub 2022 Nov 7.

Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020

Patrick S Walsh  1 , David Schnadower  1   2 , Yin Zhang  3 , Sriram Ramgopal  4   5 , Samir S Shah  2   6 , Paria M Wilson  1   2
Affiliations
Multicenter Study

Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020

Patrick S Walsh et al. JAMA Pediatr. .

Abstract

Importance: Oseltamivir is recommended for all children hospitalized with influenza, despite limited evidence supporting its use in the inpatient setting.

Objective: To determine whether early oseltamivir use is associated with improved outcomes in children hospitalized with influenza.

Design, setting, and participants: This multicenter retrospective study included 55 799 children younger than 18 years who were hospitalized with influenza from October 1, 2007, to March 31, 2020, in 36 tertiary care pediatric hospitals who participate in the Pediatric Health Information System database. Data were analyzed from January 2021 to March 2022.

Exposures: Early oseltamivir treatment, defined as use of oseltamivir on hospital day 0 or 1.

Main outcomes and measures: The primary outcome was hospital length of stay (LOS) in calendar days. Secondary outcomes included 7-day hospital readmission, late (hospital day 2 or later) intensive care unit (ICU) transfer, and a composite outcome of in-hospital death or use of extracorporeal membrane oxygenation (ECMO). Inverse probability treatment weighting (IPTW) based on propensity scoring was used to address confounding by indication. Mixed-effects models were used to compare outcomes between children who did and did not receive early oseltamivir treatment. Outcomes were also compared within high-risk subgroups based on age, presence of a complex chronic condition, early critical illness, and history of asthma.

Results: The analysis included 55 799 encounters from 36 hospitals. The median (IQR) age of the cohort was 3.61 years (1.03-8.27); 56% were male, and 44% were female. A total of 33 207 patients (59.5%) received early oseltamivir. In propensity score-weighted models, we found that children treated with early oseltamivir had shorter LOS (median 3 vs 4 days; IPTW model ratio, 0.52; 95% CI, 0.52-0.53) and lower odds of all-cause 7-day hospital readmission (3.5% vs 4.8%; adjusted odds ratio [aOR], 0.72; 95% CI, 0.66-0.77), late ICU transfer (2.4% vs 5.5%; aOR, 0.41; 95% CI, 0.37-0.46), and the composite outcome of death or ECMO use (0.9% vs 1.4%; aOR, 0.63; 95% CI, 0.54-0.73).

Conclusions and relevance: Early use of oseltamivir in hospitalized children was associated with shorter hospital stay and lower odds of 7-day readmission, ICU transfer, ECMO use, and death. These findings support the current recommendations for oseltamivir use in children hospitalized with influenza.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Shah receives funding from the Children’s Hospital Association outside the submitted work. All funding goes directly to his institution. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Study Flow Diagram
ECMO indicates extracorporeal membrane oxygenation.
Figure 2.
Figure 2.. Results of Weighted Analysis of Oseltamivir Use and Outcomes
The primary analysis compares outcomes between those treated and not treated with early oseltamivir. Sensitivity analyses compared any oseltamivir vs no oseltamivir and early oseltamivir vs no oseltamivir (excluding children treated with late oseltamivir). ECMO indicates extracorporeal membrane oxygenation; ICU, intensive care unit; IPTW, inverse probability treatment weighting.
Figure 3.
Figure 3.. Outcomes Within Subgroups Based on High-risk Conditions in Propensity Score–Weighted Analysis
CCC indicates complex chronic condition; ICU, intensive care unit; LOS, length of stay.
See this image and copyright information in PMC

References

    1. Rolfes MA, Foppa IM, Garg S, et al. . Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness. Influenza Other Respir Viruses. 2018;12(1):132-137. doi:10.1111/irv.12486 - DOI - PMC - PubMed
    1. American Academy of Pediatrics Committee on Infectious Diseases . Prevention of influenza: recommendations for influenza immunization of children, 2006-2007. Pediatrics. 2007;119(4):846-851. doi:10.1542/peds.2007-0164 - DOI - PubMed
    1. Harper SA, Bradley JS, Englund JA, et al. ; Expert Panel of the Infectious Diseases Society of America . Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003-1032. doi:10.1086/598513 - DOI - PMC - PubMed
    1. Jefferson T, Jones MA, Doshi P, et al. . Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;1:CD008965. doi:10.1590/1516-3180.20141324T2 - DOI - PubMed
    1. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-1737. doi:10.1016/S0140-6736(14)62449-1 - DOI - PubMed

Publication types